Literature DB >> 17594136

Activatory properties of lysophosphatidic acid on human THP-1 cells.

F D'Aquilio1, M Procaccini, V Izzi, V Chiurchiu', V Giambra, F Carotenuto, P Di Nardo, P M Baldini.   

Abstract

Excessive leukocyte proliferation and proinflammatory mediators release represent common phenomena in several chronic inflammatory diseases. Multiple evidences identify lysophosphatidic acid (LPA), a small lipid endowed with pleiotropic activities, as an important modulator of both proliferation and activation of different cell types involved in several inflammation-associated pathologies. However, its possible role on monocyte proinflammatory activation is not fully understood yet. Aim of the present study was to investigate LPA effects on THP-1 cells in terms of proliferation, reactive oxygen intermediates (ROI) production and release of arachidonic acid-derived inflammatory mediators. Actually, LPA significantly increased both DNA synthesis and ROI production as well as prostaglandin E(2) release and the upregulation of LPA(3) receptor expression. These findings identified LPA as both a growth factor and a triggering mediator of proinflammatory response in THP-1 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594136     DOI: 10.1007/s10753-007-9034-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  29 in total

1.  Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-gamma and attenuates the oxidative burst.

Authors:  A M Johann; A von Knethen; D Lindemann; B Brüne
Journal:  Cell Death Differ       Date:  2005-12-09       Impact factor: 15.828

Review 2.  The role of free radicals in the pathogenesis of rheumatoid arthritis.

Authors:  K Hadjigogos
Journal:  Panminerva Med       Date:  2003-03       Impact factor: 5.197

3.  Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.

Authors:  W Siess; K J Zangl; M Essler; M Bauer; R Brandl; C Corrinth; R Bittman; G Tigyi; M Aepfelbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo.

Authors:  Rossana C N Melo; Daniela L Fabrino; Heloisa D'Avila; Henrique C Teixeira; Ana Paula Ferreira
Journal:  Cell Biol Int       Date:  2003       Impact factor: 3.612

5.  Insulin-stimulated hydrolysis of phosphatidylcholine by phospholipase C and phospholipase D in cultured rat hepatocytes.

Authors:  V Donchenko; A Zannetti; P M Baldini
Journal:  Biochim Biophys Acta       Date:  1994-07-21

Review 6.  Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system.

Authors:  Edward J Goetzl; Wengang Wang; Christine McGiffert; Mei-Chuan Huang; Markus H Gräler
Journal:  J Cell Biochem       Date:  2004-08-15       Impact factor: 4.429

Review 7.  Antiproliferative strategies for the treatment of vascular proliferative disease.

Authors:  Vicente Andrés; Claudia Castro
Journal:  Curr Vasc Pharmacol       Date:  2003-03       Impact factor: 2.719

8.  Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.

Authors:  Hideo Ohta; Koichi Sato; Naoya Murata; Alatangaole Damirin; Enkhzol Malchinkhuu; Junko Kon; Takao Kimura; Masayuki Tobo; Yuji Yamazaki; Tomoko Watanabe; Mikio Yagi; Motoko Sato; Rika Suzuki; Hideko Murooka; Teruyuki Sakai; Tsuyoshi Nishitoba; Dong-Soon Im; Hiromi Nochi; Koichi Tamoto; Hideaki Tomura; Fumikazu Okajima
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

Review 9.  Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis.

Authors:  Luís Vila
Journal:  Med Res Rev       Date:  2004-07       Impact factor: 12.944

Review 10.  Cellular response to oxidative stress: signaling for suicide and survival.

Authors:  Jennifer L Martindale; Nikki J Holbrook
Journal:  J Cell Physiol       Date:  2002-07       Impact factor: 6.384

View more
  7 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

Review 2.  High-fat diet, obesity and prostate disease: the ATX-LPA axis?

Authors:  Prakash Kulkarni; Robert H Getzenberg
Journal:  Nat Clin Pract Urol       Date:  2009-02-10

Review 3.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 4.  Lysolipids in Vascular Development, Biology, and Disease.

Authors:  Eric Engelbrecht; Calum A MacRae; Timothy Hla
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-17       Impact factor: 8.311

Review 5.  Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.

Authors:  Valerio Chiurchiù; Alessandro Leuti; Mauro Maccarrone
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

Review 6.  Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation.

Authors:  Lenche Kostadinova; Carey L Shive; Donald D Anthony
Journal:  Cancers (Basel)       Date:  2019-11-25       Impact factor: 6.639

Review 7.  Lysophosphatidic acid (LPA) signaling in human and ruminant reproductive tract.

Authors:  Izabela Wocławek-Potocka; Paulina Rawińska; Ilona Kowalczyk-Zieba; Dorota Boruszewska; Emilia Sinderewicz; Tomasz Waśniewski; Dariusz Jan Skarzynski
Journal:  Mediators Inflamm       Date:  2014-03-12       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.